An update on autoantibodies in scleroderma
Authors:
- Livia Casciola-RosenLCLivia Casciola-Rosen
- 1 November 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 30 (6) , 548-553
Abstract
Purpose of review: New research continues to provide important insights into the utility of antibody specificities. This review provides an update of recent findings, and the important insights they provide into disease mechanism.Recent findings: A growing number of autoantibodies have been discovered in scleroderma patients with unique clinical associations. A subgroup of these antibodies may have functional consequences and contribute to disease pathogenesis, driving the vascular and fibrotic phenotype. Recent research into the relationship between malignancy and scleroderma onset provides important new insights into disease mechanism, and highlights the utility of autoantibodies as unique research probes.Summary: Continued advances in the study of scleroderma antibody specificities has led to important insights into disease pathogenesis and clinical subgrouping. These advances include newly described specificities, functional antibodies and an emerging understanding of the cancer–scleroderma relationship.Keywords
This publication has 33 references indexed in Scilit:
- Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic SclerosisAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle InvolvementArthritis Care & Research, 2014
- Association of anti-RNA polymerase III autoantibodies and cancer in sclerodermaArthritis Research & Therapy, 2014
- Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesisArthritis Research & Therapy, 2014
- Association of the Autoimmune Disease Scleroderma with an Immunologic Response to CancerScience, 2014
- Structural and functional insights into a dodecameric molecular machine – The RuvBL1/RuvBL2 complexJournal of Structural Biology, 2011
- Malignancies in Italian Patients with Systemic Sclerosis Positive for Anti-RNA Polymerase III AntibodiesThe Journal of Rheumatology, 2011
- Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosisRheumatology, 2010
- Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodiesArthritis & Rheumatism, 2010
- Immunohistochemical Expression Analysis of the Human Interferon-Inducible Gene IFI16, a Member of the HIN200 Family, Not Restricted to Hematopoietic CellsJournal of Interferon & Cytokine Research, 2002